Oda, Shingo <br/><br/>
Targeted screen for human UDP-glucuronosyltransferases inhibitors and the evaluation of potential drug-drug interactions with zafirlukast.  [electronic resource] 

 -  Drug metabolism and disposition: the biological fate of chemicals  Jun 2015 
 - 812-8 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1521-009X 
<br/><br/><label>Standard No.: </label>10.1124/dmd.114.062141  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Drug Evaluation, Preclinical<br/>Drug Interactions<br/>Enzyme Inhibitors--adverse effects<br/>Glucuronosyltransferase--antagonists & inhibitors<br/>Humans<br/>Indoles<br/>Intestinal Mucosa--drug effects<br/>Intestine, Small--drug effects<br/>Isoenzymes--antagonists & inhibitors<br/>Kinetics<br/>Leukotriene Antagonists--adverse effects<br/>Metabolic Detoxication, Phase II<br/>Microsomes--drug effects<br/>Microsomes, Liver--drug effects<br/>Phenylcarbamates<br/>Raloxifene Hydrochloride--metabolism<br/>Recombinant Proteins--chemistry<br/>Selective Estrogen Receptor Modulators--metabolism<br/>Small Molecule Libraries<br/>Substrate Specificity<br/>Sulfonamides<br/>Tosyl Compounds--adverse effects